Your browser doesn't support javascript.
loading
Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease.
Papadopoulos, C; Papadimas, G K; Michelakakis, H; Kararizou, E; Manta, P.
Afiliación
  • Papadopoulos C; Eginition Hospital, University of Athens, School of Medicine, Greece.
  • Papadimas GK; Eginition Hospital, University of Athens, School of Medicine, Greece.
  • Michelakakis H; Department of Enzymology and Cellular Function, Institute of Child Health, Athens, Greece.
  • Kararizou E; Eginition Hospital, University of Athens, School of Medicine, Greece.
  • Manta P; Eginition Hospital, University of Athens, School of Medicine, Greece.
Mol Genet Metab Rep ; 1: 2-4, 2014.
Article en En | MEDLINE | ID: mdl-27905573
ABSTRACT
BACKGROUND/

AIMS:

Pompe disease is a rare metabolic disorder caused by deficiency of the lysosomal enzyme acid alpha-glycosidase (GAA). The late onset form of the disease is characterized by muscle weakness and respiratory involvement of variable severity. The aim of this short communication is to highlight the clinical variability of Pompe disease within siblings suffering from the disease. CASE REPORTS We report three pairs of siblings with late-onset Pompe disease presenting with different clinical phenotypes within the spectrum of disease phenotypes.

CONCLUSION:

Clinical manifestations in Pompe disease within the same family can be very different. Clinicians should investigate patients' siblings for symptoms throughout the entire spectrum of the disease in order to avoid delays in the diagnosis and to pick-up mildly affected persons as early as possible, when they can benefit the most from enzyme replacement therapy.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Mol Genet Metab Rep Año: 2014 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Mol Genet Metab Rep Año: 2014 Tipo del documento: Article País de afiliación: Grecia